CRISPR-like technique offers clues to mimic protective genetic mutations
Using a variation of CRISPR gene editing may be a potential strategy for mimicking the protective effects of a genetic mutation linked to lower cholesterol levels and heart disease risks, according to new mouse research from the Perelman School of Medicine at the University of Pennsylvania published this week in Circulation.
People with naturally occurring mutations that cause a loss of function in the gene for ANGPTL3 have reduced blood triglycerides, LDL cholesterol, and risk of coronary heart disease, with no apparent detrimental consequences to their health. This makes the ANGPTL3 protein an attractive target for new heart disease drugs. Earlier studies at Penn found that single copies of inactivating mutations in ANGPTL3 are found in about one in every 250 people of European heritage; however, people with mutations in both copies of the gene are more rare.
A team led by Kiran Musunuru, MD, PhD, MPH, an associate professor of Cardiovascular Medicine, assessed in a mouse model whether base editing – a variation of CRISPR genome editing that does not require breaks in the double-strand of DNA – might be used in humans one day to introduce mutations into ANGPTL3 to reduce blood lipid levels.
“This proof-of-principle study showed that base-editing of ANGPTL3 is a potential way to permanently treat patients with harmful blood lipid levels,” Musunuru said. “It would be especially useful in patients with a rare condition called homozygous familial hypercholesterolemia, which causes sky-high cholesterol levels and dramatically increased risk of heart attack. They are very difficult to treat with today’s medications, and a one-time CRISPR ‘vaccination’ might be ready to use in these patients within five years.”
The study took a three-part approach. First, the team injected normal mice with the base-editing treatment for the ANGPTL3 gene. After a week, sequencing of the ANGPTL3 target site in liver samples from the mice revealed a median 35 percent editing rate in the target gene and no off-target mutations. In addition, the mean levels of blood lipids were significantly lower in the treated mice by up to 30 percent compared to untreated mice.
Second, the researchers compared mice with the modified ANGPTL3 gene to those injected with a base-editing treatment for another liver gene, PCSK9, for plasma cholesterol and triglycerides. After a week, ANGPTL3 targeting caused a similar reduction in cholesterol but a much greater decline in triglycerides compared to targeting PCSK9. The PCSK9 protein is the target of currently available medications, including evinacumab, which has been shown to reduce cholesterol (but not triglycerides) as well as the risk of heart attack and stroke.
Third, they looked at how base editing of the ANGPTL3 gene performed in a mouse model of homozygous familial hypercholesterolemia (in which knocking out PCSK9 had little effect). After two weeks, the treated mice showed substantially reduced triglycerides (56 percent) and cholesterol (51 percent) compared to untreated mice.
Musunuru’s lab is now preparing to test CRISPR-based treatments against the human ANGPTL3 gene in human liver cells transplanted into mice. This will provide important information on efficacy and safety that will be needed before human trials can move forward.
The Latest on: Gene editing
- Robin Cook’s new novel, ‘Pandemic,’ spotlights perils of gene-editing technology on December 20, 2018 at 8:00 am
When there’s a scientific breakthrough, best-selling author Robin Cook doesn’t just stand and cheer. He writes a novel about its possible perils. In his latest medical thriller, “Pandemic ... […]
- Can ‘speed breeding’ help Europe develop disease-resistant crops without gene editing? on December 20, 2018 at 4:18 am
Technology first used by the National Aeronautics and Space Administration to grow plants in space is fast-tracking improvements in a range of crops. Scientists at the United Kingdom’s John ... […]
- On gene editing on December 19, 2018 at 11:04 pm
A Chinese scientist, Jiankui He, last month announced the birth of twin babies whose genes he claims to have modified while they were embryos. On that day, the world woke up to the realization that th... […]
- We’ll Need Property Rights In A World Of Gene-Edited Humans – OpEd on December 19, 2018 at 6:27 pm
That it seems to be at least somewhat acceptable to screen embryos (or sperm or eggs cells) for signs of disease before use, but not to use these gene-editing techniques to fix (or attempt to fix) or ... […]
- In the First Year of Release, Inscripta's MAD7 CRISPR Enzyme is Widely Adopted by the Gene-Editing Community on December 19, 2018 at 6:00 am
BOULDER, Colo., Dec. 19, 2018 /PRNewswire/ -- Inscripta™, a leading gene-editing technology company, today announced that MAD7, its proprietary CRISPR enzyme, has achieved wide adoption by academic, c... […]
- Animal gene editing could ‘transform’ our food supply, but will regulation stand in the way? on December 19, 2018 at 4:47 am
Hornless heifer calf #1 of gene-edited bull alongside horned Hereford control calf on right (Image source: Alison Van Eenennaam/Twitter) So far, gene-editing tools have jump-started research ... […]
- The Ethics of Genetically Editing Babies on December 19, 2018 at 3:06 am
Ever since scientists created the powerful gene-editing technique Crispr, they have braced for the day when it would be used to produce a genetically altered human being. Now, the moment they feared m... […]
- Gene-Editing Stocks Took Stutter Steps Forward in 2018 on December 18, 2018 at 5:35 am
The prospect of deleting gene mutations or inserting code into DNA to address genetic diseases is exciting, but questions remain for gene-editing approaches. Delays and concern over off-target impacts ... […]
- Gene editing demands caution and consensus on December 18, 2018 at 2:35 am
A Chinese scientist's claim to have edited the genes of human embryos has provoked condemnation from scientists worldwide, and rightly so. He Jiankui barged ahead without ensuring that the genetic cha... […]
- Gene-edited farm animals are coming. Will we eat them? on December 17, 2018 at 1:48 pm
The new gene-editing attempt is even more audacious. For farmers seeking to maximize beef production, all-male cattle could be a win: Males gain weight more efficiently than females. For scientists, s... […]
via Google News and Bing News